{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:30:49Z","timestamp":1793917849557,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Anhui Provincial Key Research and Development Plan","award":["2023s07020012"],"award-info":[{"award-number":["2023s07020012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46680-x","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:45:50Z","timestamp":1774986350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Modifying VEGF-A mRNA by combinatorial optimization to enhance therapeutic efficacy for myocardial infarction"],"prefix":"10.1038","volume":"16","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"46680_CR1","doi-asserted-by":"publisher","first-page":"963689722109025","DOI":"10.1177\/09636897221090259","volume":"31","author":"AYL Wang","year":"2022","unstructured":"Wang, A. Y. L. Modified mRNA-based vaccines against coronavirus disease 2019. Cell. Transpl. 31, 9636897221090259 (2022).","journal-title":"Cell. Transpl."},{"key":"46680_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/wrna.1288","volume":"6","author":"B Vallazza","year":"2015","unstructured":"Vallazza, B. et al. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond. Wiley Interdiscip. Rev. RNA. 6, 471\u2013499 (2015).","journal-title":"Wiley Interdiscip Rev. RNA"},{"key":"46680_CR3","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1182\/blood-2006-04-015024","volume":"108","author":"S Holtkamp","year":"2006","unstructured":"Holtkamp, S. et al. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Blood 108, 4009\u20134017 (2006).","journal-title":"Blood"},{"key":"46680_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","volume":"24","author":"L P\u00e9rez-Guti\u00e9rrez","year":"2023","unstructured":"P\u00e9rez-Guti\u00e9rrez, L. & Ferrara, N. Biology and therapeutic targeting of vascular endothelial growth factor A. Nat. Rev. Mol. Cell. Biol. 24, 816\u2013834 (2023).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"46680_CR5","doi-asserted-by":"publisher","first-page":"14845","DOI":"10.3390\/ijms131114845","volume":"13","author":"D Sa-Nguanraksa","year":"2012","unstructured":"Sa-Nguanraksa, D. & O-Charoenrat, P. The role of vascular endothelial growth factor a polymorphisms in breast cancer. Int. J. Mol. Sci. 13, 14845\u201314864 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"46680_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1586\/14779072.3.3.521","volume":"3","author":"GC Hughes","year":"2005","unstructured":"Hughes, G. C. & Annex, B. H. Angiogenic therapy for coronary artery and peripheral arterial disease. Expert Rev. Cardiovasc. Ther. 3, 521\u2013535 (2005).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"46680_CR7","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1158\/0008-5472.CAN-09-4580","volume":"70","author":"YA Yeung","year":"2010","unstructured":"Yeung, Y. A. et al. A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-life. Cancer Res. 70, 3269\u20133277 (2010).","journal-title":"Cancer Res."},{"key":"46680_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1146\/annurev.biochem.73.011303.074032","volume":"73","author":"J Coller","year":"2004","unstructured":"Coller, J. & Parker, R. Eukaryotic mRNA decapping. Annu. Rev. Biochem. 73, 861\u2013890 (2004).","journal-title":"Annu. Rev. Biochem."},{"key":"46680_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/pharmaceutics7030137","volume":"7","author":"S Uchida","year":"2015","unstructured":"Uchida, S., Kataoka, K. & Itaka, K. Screening of mRNA chemical modification to maximize protein expression with reduced immunogenicity. Pharmaceutics 7, 137\u2013151 (2015).","journal-title":"Pharmaceutics"},{"key":"46680_CR10","doi-asserted-by":"publisher","first-page":"gkaf963","DOI":"10.1093\/nar\/gkaf963","volume":"53","author":"T Lu","year":"2025","unstructured":"Lu, T. et al. N1-methylpseudouridine mRNA modification enhances efficiency and specificity of gene overexpression by preventing Prkra-mediated global translation repression. Nucl. Acids Res. 53, gkaf963 (2025).","journal-title":"Nucleic Acids Res."},{"key":"46680_CR11","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell. Stem Cell. 7, 618\u2013630 (2010).","journal-title":"Cell. stem cell."},{"key":"46680_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/nrm.2017.103","volume":"19","author":"K Leppek","year":"2018","unstructured":"Leppek, K., Das, R. & Barna, M. Functional 5\u2032 UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat. Rev. Mol. Cell. Biol. 19, 158\u2013174 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"46680_CR13","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/biom13111677","volume":"13","author":"A Kirshina","year":"2023","unstructured":"Kirshina, A. et al. Effects of combinations of untranslated-region sequences on translation of mRNA. Biomolecules 13, 1677 (2023).","journal-title":"Biomolecules"},{"key":"46680_CR14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41587-024-02393-y","volume":"43","author":"H Chen","year":"2025","unstructured":"Chen, H. et al. Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation. Nat. Biotechnol. 43, 1128\u20131143 (2025).","journal-title":"Nat. Biotechnol."},{"key":"46680_CR15","doi-asserted-by":"publisher","first-page":"eadr8470","DOI":"10.1126\/science.adr8470","volume":"390","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. Deep generative models design mRNA sequences with enhanced translational capacity and stability. Science 390, eadr8470 (2025).","journal-title":"Science"},{"key":"46680_CR16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-023-06127-z","volume":"621","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Algorithm for optimized mRNA design improves stability and immunogenicity. Nature 621, 396\u2013403 (2023).","journal-title":"Nature"},{"key":"46680_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41573-021-00355-6","volume":"21","author":"A Coll\u00e9n","year":"2022","unstructured":"Coll\u00e9n, A. et al. VEGFA mRNA for regenerative treatment of heart failure. Nat. Rev. Drug Discov. 21, 79\u201380 (2022).","journal-title":"Nat. Rev. Drug Discov"},{"key":"46680_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","volume":"23","author":"D Bitounis","year":"2024","unstructured":"Bitounis, D., Jacquinet, E., Rogers, M. A. & Amiji, M. M. Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat. Rev. Drug Discov. 23, 281\u2013300 (2024).","journal-title":"Nat. Rev. Drug Discov"},{"key":"46680_CR19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nbt.2682","volume":"31","author":"L Zangi","year":"2013","unstructured":"Zangi, L. et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898\u2013907 (2013).","journal-title":"Nat. Biotechnol."},{"key":"46680_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1096\/fj.01-0986fje","volume":"16","author":"KD Wagner","year":"2002","unstructured":"Wagner, K. D. et al. The Wilms\u2019 tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J. 16, 1117\u20131119 (2002).","journal-title":"FASEB J."},{"key":"46680_CR21","doi-asserted-by":"publisher","first-page":"e0177523","DOI":"10.1128\/mbio.01775-23","volume":"15","author":"J Wan","year":"2024","unstructured":"Wan, J. et al. Circular RNA vaccines with long-term lymph node-targeting delivery stability after lyophilization induce potent and persistent immune responses. mBio 15, e0177523 (2024).","journal-title":"mBio"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46680-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46680-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:09:39Z","timestamp":1779102579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46680-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46680"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46680-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8268281\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal use was approved by the Institutional Animal Care and Use Committee (IACUC). Animal welfare conformed to the Guide for the Care and Use of Laboratory Animals (8th ed., 2011) and Chinese national standard Guideline for Ethical Review of Laboratory Animal Welfare (GB\/T 35892\u2009\u2212\u20092018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"15254"}}